Description
Impact of Vedolizumab on immune cell homing to the female reproductive and gastrointestinal mucosa
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02017-06-01$249,460
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2017-06-01(start date) | $249,460 | — | Impact of Vedolizumab on immune cell homing to the female reproductive and gastrointestinal mucosa |
Related records · 6
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2025-2026-Q4-00121 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $100,000 | FY2026 |
| 236-2023-2024-Q2-00500 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $450,000 | FY2024 |
| 236-2022-2023-Q1-00924 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $837,675 | FY2023 |
| 236-2022-2023-Q1-01055 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $25,000 | FY2023 |
| 236-2021-2022-Q3-00291 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $300,000 | FY2022 |
| 236-2021-2022-Q1-00236 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $749,700 | FY2022 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2017-2018-Q1-00636 · retrieved 2026-11-14.